Today: 26 March 2026
Subscribe
Browse Category

Stock Market 24 February 2026

SanDisk stock steadies after Citron short call; SNDK traders watch next catalysts

SanDisk stock steadies after Citron short call; SNDK traders watch next catalysts

Sandisk shares rose 1.3% to $675.19 Tuesday morning after Citron Research disclosed a short position and warned the NAND chip shortage could end quickly. The stock dipped briefly after Citron’s post before rebounding. Citron cited rising competition, especially from Samsung, as a risk. Investors are watching Sandisk’s conference appearances starting Feb. 25 for updates.
24 February 2026
··
Aeromexico stock price today: AERO rises after Mexico airport disruption update

Aeromexico stock price today: AERO rises after Mexico airport disruption update

Grupo Aeromexico shares rose 1.1% to $19.05 after the airline said it was restoring flights at four western Mexico airports disrupted by recent violence. Major carriers, including American and United, had suspended flights after cartel-related attacks. Aeromexico expects regular schedules to resume by Tuesday, noting limited impact on its network. Mexico’s main stock index fell 0.36% in early trading.
24 February 2026
··
Datadog stock slides in early trade as Anthropic’s AI security tool keeps investors wary

Datadog stock slides in early trade as Anthropic’s AI security tool keeps investors wary

Datadog shares fell 1.3% to $101.24 in early Tuesday trading after AI startup Anthropic launched Claude Code Security, a tool targeting software vulnerabilities. Other cybersecurity stocks and IBM also dropped sharply Monday on similar concerns. Datadog recently beat Q4 estimates with $953.2 million in revenue and forecast Q1 revenue of $951–$961 million. A Form 144 filing showed insider Alexis T. LeQuoc proposed selling 21,612 shares.
24 February 2026
···
Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis Systems shares rose about 2.4% to $21.59 Tuesday morning after plunging 11% the previous day. A law firm said a securities class action was filed for investors who bought between Feb. 4 and Oct. 28, 2025, with a lead-plaintiff deadline set for March 9. The company remains under scrutiny as it shifts to SaaS subscriptions and faces a projected $30–$50 million 2026 revenue hit from government clients not converting.
24 February 2026
··
Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable shares closed down nearly 12% at $17.55 on Monday, hitting fresh 52-week lows after Anthropic launched an AI security tool targeting open-source code. The stock was little changed in premarket trading Tuesday, with heavy volume following the sector-wide selloff. Investors are watching for further moves at the open and a March 3 company presentation for signs of demand and competition.
24 February 2026
···
RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral shares rose 0.6% to $34.79 in premarket trading Tuesday after a 12.5% drop Monday and a 34% jump Friday. Piper Sandler raised its price target to $37 but kept a neutral rating, citing pricing pressure and dilution risk. The board approved a quarterly dividend of $0.075 per share, payable March 16 to holders as of March 9. Investors are watching if the post-earnings rally holds.
24 February 2026
··
IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM shares rose 0.7% in premarket trading Tuesday after plunging 13% Monday, their steepest drop since 2000. The selloff followed Anthropic’s claim that its Claude Code AI tools can speed up COBOL modernization, raising concerns over IBM’s mainframe services. IBM pushed back, saying platform modernization is more complex than code translation. Investors are watching IBM’s March 3 conference for further comments.
24 February 2026
···
Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.
24 February 2026
···
IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN Limited shares fell 1.5% to $41.72 in premarket trading Tuesday, after jumping nearly 6% Monday ahead of its addition to the MSCI USA Index. Cantor Fitzgerald disclosed holdings of 3.47 million shares and put options on 5.03 million shares. Bitcoin dropped 5.3% to $62,693, pressuring crypto-linked stocks. IREN recently reported $2.8 billion in cash and secured $3.6 billion in GPU financing for a Microsoft contract.
24 February 2026
·
AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
···
Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold shares closed up 6.25% in Toronto on Monday after the company declared its first quarterly dividend and applied for a share buyback. U.S.-listed shares last traded at $17.85, up about 6% after hours. The company reported net debt of $75 million at Jan. 31 after reducing debt by $1.1 billion since mid-2025. Gold prices fell over 1% on Tuesday, posing a near-term challenge for miners.
24 February 2026
···
NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR shares rose 2.5% to $26.70 in premarket trading Tuesday after a 6.8% jump the prior session, nearing the top of their 52-week range. The company reported Q4 revenue of $398.3 million and adjusted EPS of $0.32, beating estimates, but net income fell to $7.8 million due to impairment and restructuring charges. Management is scheduled to meet investors at conferences in Houston and Las Vegas.
24 February 2026
··
Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics shares rose 6.3% to $52.68 Monday ahead of CEO Marino Garcia’s scheduled fireside chat at TD Cowen’s health care conference on March 3. Volume reached about 944,000 shares. Investors are watching for updates on the company’s autoimmune pipeline and trial timelines. The event will be webcast and include one-on-one investor meetings.
24 February 2026
··
Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy shares fell 1.6% to $157.80 in premarket trading Tuesday after an 8.6% surge the previous session. Director Jeffrey Immelt disclosed gifting 4,000 shares in a late Monday SEC filing. Tariff uncertainty and Nvidia’s results this week are influencing AI-linked stock moves. Bloom’s 2026 revenue forecast stands at up to $3.3 billion, with a reported backlog of about $20 billion.
24 February 2026
··
Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
·
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
24 February 2026
··
1 … 69 70 71 72 73 … 1,363

Stock Market Today

  • Globalstar Shares Surge 10.3% on SpaceX IPO Speculation Amid Satellite Industry Growth
    March 26, 2026, 9:51 AM EDT. Globalstar (GSAT) shares jumped 10.3% to $67.38, driven by SpaceX IPO speculation that has buoyed the satellite sector. The company reported 2025 revenue of $273 million, up 9%, with a 50% Adjusted EBITDA margin. Despite expected quarterly losses narrowing and revenues rising 17.7%, consensus earnings estimates have been revised down 250% in 30 days, tempering enthusiasm. Globalstar's expansion plans include launching next-gen satellites and boosting 5G services. Satellite firm Gilat (GILT) also gained 3.5%, reflecting broader industry momentum. Investors should watch GSAT for sustained strength amid mixed earnings outlooks.
Go toTop